U.S. FDA classifies Aurobindo arm’s North Carolina plant VAI

With the unit classified as Voluntary Action Indicated (VAI), pending applications for multiple inhalers and other dosage forms filed from this facility can now progress through the U.S. FDA’s review process, the parent company said